Inception Growth Acquisition Ltd

Inception Growth Acquisition Ltd is a U.S.-listed blank check company formed to find and merge with an operating business through a business combination, such as a merger, share exchange, or asset acquisition. It has no operating revenue and exists primarily to hold IPO proceeds in trust while management searches for a target and negotiates a transaction before the deadline.

0.01

0.01

— Inception Growth Acquisition Ltd
%
SPAC formation and capital structure0% IPO units, public shares, warrants, and rights issued to fund the search for a target.
Business combination execution0% Merger, share exchange, asset acquisition, or similar transaction with a target company.
Trust account and extension financing0% Deposits into the trust account to extend the deadline for completing a business combination.

The company does not sell products or services to operating customers; its economic counterparties are investors,...

  • Public investorsprimary

    Buy units, shares, warrants, and rights for exposure to a future acquisition and redemption optionality.

  • Potential acquisition targetsprimary

    Private operating businesses that may combine with the SPAC to access public capital markets.

  • Sponsor and insider capital providerssecondary

    Provide funding, extension support, and governance to keep the search process alive.

  • Warrant and rights holderssecondary

    Hold optionality tied to a successful business combination and post-deal equity value.

Inception Growth Acquisition Ltd is incorporated in Delaware and operates as a U.S.-based public company...

  • •Incorporated in Delaware and based in the United States
  • •Listed and financed through U.S. public markets
  • •No operating manufacturing or service footprint today
  • •Future geography will depend on the target acquired
  • •Current exposure is mainly to U.S. securities law and SPAC rules

The company’s core strategy is to complete an initial business combination before the extended deadline, using trust...

01
Complete an initial business combinationshort-term

The company has no operating business or revenue until a transaction closes.

02
Manage deadline extensionsshort-term

Extensions buy time to negotiate and diligence a target, but require trust deposits.

03
Preserve transaction optionalitymedium-term

A flexible capital structure improves the chance of closing a deal and avoiding liquidation.

The main risk is failure to complete a business combination before the deadline, which would trigger redemption of...

critical

Failure to consummate a business combination by the deadline

Without a closing, the company must redeem public shares and liquidate.

Scope
Public shareholders, warrants, and rights
Materiality
high
high

Need for additional financing and extension deposits

The company has limited operating cash and must fund trust extensions and expenses.

Scope
Operating liquidity and deal execution
Materiality
high
high

SPAC market and transaction execution risk

Target quality, valuation, and shareholder approval can derail a de-SPAC process.

Scope
Deal completion and post-merger performance
Materiality
high
medium

Warrant valuation and classification risk

Warrants may be equity- or liability-classified depending on terms and guidance.

Scope
Reported earnings and balance sheet volatility
Materiality
medium
Warrant accounting
Can materially change reported earnings and balance sheet presentation
Fair value measurement of warrants
Creates non-cash gains or losses and quarterly volatility
Deferred underwriting discount
Affects transaction closing economics and cash available after merger
Trust account and redemption accounting
Directly affects shareholder recovery and liquidity analysis

Hi-Great Group Holding Co

HIGR · Hotels & Motels

Gain Therapeutics, Inc.

GANX · Pharmaceutical Preparations

IGTA Merger Sub Ltd

Services-Computer Programming, Data Processing, Etc.

K&F GROWTH ACQUISITION CORP. II

KFII · Blank Checks

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ · Biological Products, (No Diagnostic Substances)

Evolution Global Acquisition Corp

EVOX · Blank Checks

: 28.4.2026